Joseph B. Armes - 01 Oct 2026 Form 4 Insider Report for CSW INDUSTRIALS, INC. (CSW)

Reporting relationship: Chairman, President & CEO, Director
Issuer ticker: CSW
Reported as of: 01 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Oct 2026, 16:08:25 UTC
Prior SEC filing: 16 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes

Key filing fact

Joseph B. Armes filed Form 4 for CSW INDUSTRIALS, INC. (CSW) on 05 Oct 2026.

Key facts

This page summarizes Joseph B. Armes's Form 4 filing for CSW INDUSTRIALS, INC. (CSW).
2 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 05 Oct 2026, 16:08.

Change

Previous filing in this sequence was filed on 16 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001413614 Primary reporting owner

Armes Joseph B

Relationship: Chairman, President & CEO, Director
Address: 5420 LYNDON B JOHNSON FWY, STE. 500, DALLAS
Signature: /s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes
Signature date: 05 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSW transaction

Common Stock

Award

Transaction value
Shares: +5,095
Change %: +8.1%
Price: $0.000000^*
Shares after: 67,831
Date: 01 Oct 2026
Ownership: Direct
Footnotes: F1

CSW transaction

Common Stock

Tax liability

Transaction value
Shares: -2,248
Change %: -3.3%
Price: $292.38^*
Shares after: 65,583
Date: 01 Oct 2026
Ownership: Direct

CSW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,219
Date: 01 Oct 2026
Ownership: by ESOP

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSW holding Derivative

Performance Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,836
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,836
Exercise price
Footnotes: F2

CSW holding Derivative

Performance Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,004
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,004
Exercise price
Footnotes: F3

CSW holding Derivative

Performance Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,236
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,236
Exercise price
Footnotes: F4

CSW holding Derivative

Performance Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,186
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,186
Exercise price
Footnotes: F5

CSW holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,685
Date: 01 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,685
Exercise price
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Footnote F2

Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Footnote F3

Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Footnote F4

Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Footnote F5

Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Footnote F6

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .